Main outcome measures-Aspects of quality of outpatient care (blood testing, clinic attendance, and prophylactic drug treatment) and family care (adequate support and carers' knowledge about the disease) as assessed by reviewing the notes and administering a semistructured questionnaire to the carers, in relation to a devised list of standards deemed necessary to ensure achievement of the aims of screening.
Introduction
The case for neonatal screening for sickle cell disease is compelling,' although its effectiveness has never been formally evaluated in a randomised controlled trial. One approach to its indirect evaluation, adopted in two studies from New York state in the early 1980s,45 is to assume that screening can be only as effective as the care subsequently given to children identified on screening and to assess the quality of care by, for instance, determining whether prophylactic penicillin is taken regularly, which is crucial to reduce the incidence of pneumococcal infection.6 I followed the same approach in a study of children with sickle cell disease at a central London teaching hospital, most of whom had been identified outside the neonatal screening programme, which was new at the time. I sought to elucidate leave out the ability of the hospital to deliver care of sufficient quality for the new programme's aims-namely, to reduce the morbidity and mortality from sickle cell disease-was achievable.
Patients and methods
Children were said to have sickle cell disease if one of the sickle haemoglobinopathies (including HbSS and HbSC diseases as well as HbS/13 thalassaemia) had been diagnosed on haemoglobin electrophoresis. Children with sickle cell disease were entered into the study if they were born between 1978 and 1985 and if they were the hospital's responsibility, having been in its care at least once (whether as an inpatient or an outpatient or being born there) and without good evidence ofbeing in the care of another hospital.
The standards of care I examined were those thought to be necessary to reduce morbidity and mortality from sickle cell disease by a combination of preventive and therapeutic measures. A list of standards was compiled after reviewing the literature and revised after discussions with all consultants concerned with the care of young children with sickle cell disease (box). It 
Results
Thirty one children identified as the current responsibility of the hospital were entered into the study, and 25 carers, comprising 23 mothers and 2 grandmothers, representing 26 ofthe children agreed to be interviewed. The register did not include all children who might have been eligible for entry into the study. Review of the death certificates disclosed one name which had not appeared in any of the sources used to compile the register, but it was not considered appropriate to enter this child into the study. Also, four named children, born in 1984-5, though identified from the haemoglobin electrophoresis register as having sickle cell anaemia on neonatal screening, had never been followed up as outpatients. By comparison only four children with sickle cell anaemia born in those years had been followed up after diagnosis. Of the carers of 26 of the children, nine said they had been given a diagnostic card (with the child's name and detailed result of haemoglobin electrophoresis), which all nine still had. The numbers ofchildren who had three of the blood tests deemed necessary for good care in the list of minimum standards (full blood count and reticulocyte count in the past year and blood group (ever)) were 27, 22, and 11, respectively. Only eight of the 31 had had all three tests; three had had none. Regular weighing is an important tool in paediatrics, but 13 children did not meet the standard ofhaving been weighed at least twice in the previous two years; seven of the 31 children had not been weighed at all in that time.
PROPHYLACTIC DRUGS
Three aspects of prophylactic drug treatment were examined: that penicillin (or erythromycin in the case of allergy to penicillin) and folic acid should be prescribed; that they should be given at the right frequencies (penicillin twice daily and folic acid once daily); and that their names should be readily recalled by the carers. Only 12 (46%) ofthe 26 children interviewed (11 (61%) of the 18 children with sickle cell anaemia) met all of these criteria. Of the 31 children in the study 25 (8 1%) were prescribed penicillin and 29 (94%) folic acid. Of 24 carers of children in the second group who were interviewed, three could not remember the name of the drug; three gave it less than once a day.
The carers of 18 children with sickle cell anaemia (those at highest risk therefore of pneumococcal infection) were interviewed. Seven children (39%) seemed inadequately protected against pneumococcal infection; two were receiving no prophylactic pencillin at all (one because the drug had not been prescribed), another was receiving prophylactic penicillin only about one month in four, and four were said not to receive penicillin for 24 hours or more at least once a week.
GENETIC ASPECTS
Carers were asked three questions about genetic aspects of the disease: its cause ("Why do you think she or he has sickle cell disease?"); its course ("Will it ever go away entirely?"); and the risk to future children ("Ifyou had any more children, is there a chance they might have sickle cell disease"). Incorrect answers included "don't know," "don't know" or "yes," and "don't know" or "no," respectively. Sixteen of the 25 carers failed to answer all three questions correctly, and 14 said that no Prescribirig prophylactic penicillin is crucial if neonatal screening is to benefit young children with sickle cell disease. -3 '°I identified shortcomings in medical care (children not being prescribed prophylactic drugs) and family care (carers not knowing the names of the drugs or giving them incorrectly). It might be considered that the standards of care set in the study were too strict and that effort should be concentra'ted on children with HbSS disease (although those with HbSC disease may also have an increased incidence of pneumococcal infection2"). But a third of the children with sickle cell anaemia interviewed (seven of 18) were regularly without penicillin for a day or longer and were probably inadequately protected against pneumoccal infection.12 For these children much of the value of having had their sickle cell disease diagnosed at birth was lost. Some of the benefit of prescribing prophylactic penicillin may derive from its availability at home and being readily used in the event of a febrile illness.' 6 Even with this optimistic interpretation, however, two children were unprotected.
Other results are no more encouraging. Griffiths et al reported that in Birmingham in an unstated proportion of children prophylactic penicillin was not accepted after neonatal screening.'3 In one of the studies in New York state 11 of 18 parents did not recall being given any advice about pneumococcus prophylaxis,4 and in the other only four of 14 children received prophylactic penicillin before first symptoms.' The greater use of prophylactic penicillin in this study might be related to the diagnosis ofsickle cell disease on neonatal screening in a lower proportion of children than in American studies (45% v 100%). Other explanations include changes in usual paediatric practice during the years between the studies or differences in provision of health care.
Carers should surely have some understanding of the genetics of sickle cell disease,' 141-6 though this was not specified in the standards. It was disturbing that fewer than half the carers could answer all three questions about the genetics of the disease correctly and that fewer than half said that anyone had ever discussed such subjects with them. These results are no better than those from the United States. Warren et al found that 14 of 15 carers thought that the disease was inherited and that future children might be affected,4 and Rowley and Huntzinger reported that nine of 14 carers had been given genetic counselling.5 My study examined the care given only to children identified from hospital sources. As these sources were incomplete some affected children known to the hospital will have been missed (particularly those born before 1981, who would have had most contact with the hospital in the years least covered by the sources examined). Furthermore, a community study might have identified two more groups who should have been the responsibility ofthe hospital. Firstly, some children with a doctor's diagnosis of sickle cell disease will never have received care at the hospital: in this group were the child who had died, whose name was not in the sources used, and the four children whose disease was diagnosed on neonatal screening and who were not followed up. Secondly, some children, an unknown number, in the hospital's catchment population will never even have had their disease diagnosed. Nevertheless, these selection biases do not weaken the central conclusion of the study as the children missed seemed likely to have received worse care than those identified. It is also important that the register of affected children compiled in the study was more complete than any of its constituent sources, none of which included more than 60% of the study children. The absence of such a register in usual practice and the difficulties experienced in compiling one make it hard to ensure adequate follow up for all children identified and to monitor that provided.
There is no reason to suppose that the care the individual children received was any worse than that received elsewhere. The problem lies more in the effectiveness of the care received by the whole population of young children with sickle cell disease. To be effective such care must be carefully organised, in a proactive and systematic way. This conclusion is not new. Many in the past 15 years have observed that screening for sickle cell disease will not achieve its full potential without a programme that links follow up with diagnosis,1-6 71 (as for any disease '9) . Yet this study suggests that it remains as difficult as ever to offer well organised and systematic follow up to every baby born with sickle cell disease. It will be crucial to develop such a system as an integral part of any screening programme if we are to achieve "optimal management of sickle cell disease from the time of (193 males, 261 females) referred internally (through the outpatient clinic or by other hospital colleagues). The age distribution of the two groups was similar (median age (range) 48 (13-91) years and 51 (14-92) years respectively).
A x2 test was used to compare differences in the prevalence of upper gastrointestinal disease and in the proportion of abnormal and normal findings on gastroscopy in each group. In examinations in which bile reflux was present in a stomach with normal mucosa the findings were reported as normal; analysis of our data taking simple bile reflux as an abnormal finding did not alter our conclusions.
Results
Table I summarises the endoscopic findings. Accepting unselected patients for upper gastrointestinal endoscopy did not result in an increase in the proportion of examinations that disclosed normal findings. Furthermore, the proportions of patients with gastro-oesophageal reflux disease (hiatus hernia, oesophagitis, benign ulceration, and stricture) and
